Acute Ischemic Stroke Clinical Trial
Official title:
A Single-center, Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate the Tolerability, Safety, and PK Characteristics of SIM1910-09 After Single/Multiple Dosing in Healthy Chinese Volunteers
This is a single-center, randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the tolerability, safety, and pharmacokinetic characteristics of SIM1910-09 for injection after single/multiple dosing in healthy Chinese adult volunteers.
This is a double-blind, randomized, placebo-controlled, sequential-group study with intravenously (IV) administered SIM1910-09 in healthy human subjects to assess the safety, tolerability and pharmacokinetic parameters, which include of single ascending dose part and multiple ascending doses part. The primary objectives of this study are to assess the safety and tolerability of SIM1910-09 in healthy subjects. Secondary objectives are to determine the pharmacokinetics of SIM1910-09 and SCR-6401 (primary metabolite) after administration of SIM1910-09. Exploratory objectives are to learn the inhibitory effect of SIM1910-09 and SCR-6401 on inflammation cytokine in ex vivo blood. ;
NCT number | NCT05200728 |
Study type | Interventional |
Source | Jiangsu Simcere Pharmaceutical Co., Ltd. |
Contact | Ru Lin |
Phone | 86-15521381683 |
[email protected] | |
Status | Recruiting |
Phase | Phase 1 |
Start date | December 2, 2021 |
Completion date | December 31, 2022 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04069546 -
The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency
|
N/A | |
Recruiting |
NCT04415164 -
Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke
|
Phase 4 | |
Recruiting |
NCT05070260 -
Adaptive Efficacy and Safety Study of Glenzocimab Used as an add-on Therapy on Top of Standard of Care un the 4.5 Hours Following an Acute Ischemic Stroke
|
Phase 2/Phase 3 | |
Completed |
NCT03366818 -
New Stent Retriever, VERSI System for AIS
|
N/A | |
Not yet recruiting |
NCT04984577 -
Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
|
Phase 2 | |
Completed |
NCT02223273 -
Brazilian Intervention to Increase Evidence Usage in Practice - Stroke (BRIDGE-Stroke)
|
N/A | |
Completed |
NCT02586233 -
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT01594190 -
Physical Activity Immediately After Acute Cerebral Ischemia
|
N/A | |
Terminated |
NCT01694381 -
Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor
|
Early Phase 1 | |
Completed |
NCT01120301 -
Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
|
Phase 3 | |
Completed |
NCT01021319 -
Identification of Stroke Patients ≤ 3 and ≤ 4.5 Hours of Symptom Onset by Fluid Attenuated Inversion Recovery (FLAIR) Imaging and Diffusion Weighted Imaging (DWI)
|
||
Completed |
NCT00963989 -
Imaging Guided Patient Selection for Interventional Revascularization Therapy
|
N/A | |
Recruiting |
NCT00710164 -
Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke
|
Phase 2/Phase 3 | |
Completed |
NCT00777140 -
Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion
|
Phase 2 | |
Recruiting |
NCT04072705 -
Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke
|
||
Not yet recruiting |
NCT03669653 -
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Ischemic Stroke
|
N/A | |
Completed |
NCT04240470 -
Endovascular Stroke Treatment Only (ESTO) Trial
|
N/A | |
Not yet recruiting |
NCT04488692 -
Early Functional Training in Acute Stroke Inpatient Ward
|
N/A | |
Active, not recruiting |
NCT05101668 -
Safety and Efficacy of Intracranial Thrombus Aspiration Catheter in the Treatment of Acute Large-vessel Occlusive Stroke
|
N/A | |
Recruiting |
NCT03680469 -
The Effectiveness of Early Mobilization for Acute Ischemic Stroke Treated With Rt-PA or IA Thrombectomy
|
N/A |